Patients using Raloxifene have an increased chance of developing blood clots in their legs or lungs. Blood clots in the lungs, legs, or eyes can be fatal. Inform your doctor about it if necessary. It is not advised to take Raloxifene. Very likely, your doctor will tell you not to take this drug. If you suffer any of the following negative effects while taking Raloxifene: Shortness of breath, blood in the cough, or rapid changes in vision, such as blurring or loss of vision, can all be symptoms of angina. The same goes for swelling, pain, or warmth in the lower leg.
Those who spend a lot of time sitting have a higher risk of developing a blood clot. Your doctor advises that you stop using Raloxifene and not use it for any other reason at least three days before to surgery. Be sure to inform your doctor in advance of any planned surgery if you plan to take Raloxifene. When using Raloxifene, avoid sitting still for prolonged periods of time, such as in a car or aeroplane.
For pre-existing or high-risk coronary artery disease, taking Raloxifene UK is related with an elevated risk of a severe or fatal stroke. Tell your doctor right away if you’ve ever experienced any health issues. Examples of this include elevated blood pressure and an irregular heartbeat.
Your physician or pharmacist will give you the patient information manual from the manufacturer before you start taking Raloxifene (Medication Guide). You will receive a fresh prescription each time you come in for a refill.
Osteoporosis in postmenopausal women is frequently treated and prevented using Raloxifene. Osteoporosis can also be treated with Raloxifene. For postmenopausal women at high risk of breast cancer or osteoporosis, Raloxifene is an alternative. Raloxifene is given to these women in order to relieve their symptoms. It is not possible to use Raloxifene to treat women who have already had invasive breast cancer. It is not possible to reduce the risk of noninvasive breast cancer with Raloxifene. Raloxifene should not be used in women who have not yet reached menopause. The class of drugs known as selective oestrogen receptor modulators includes Raloxifene (SERMs). Raloxifene is used in women to cure and prevent bone loss since it mimics the actions of oestrogen. Bone density may rise as a result of Raloxifene (thickness). Since Raloxifene inhibits the growth of breast tissue by inhibiting the oestrogen receptor, it lowers the risk of invasive breast cancer. It’s possible to avoid tumors that need oestrogen to grow, but this is not a given.